Skip to content

Clinical characteristics and multidisciplinary management of patients with retroperitoneal fibrosis–related hydronephrosis

Clinical characteristics and multidisciplinary management of patients with retroperitoneal fibrosis–related hydronephrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128615
Enrollment
Unknown
Registered
2026-07-23
Start date
2026-07-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteral stricture and hydronephrosis secondary to retroperitoneal fibrosis

Interventions

Observation Group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who received medical care at West China Hospital, Sichuan University, with suspected or confirmed retroperitoneal fibrosis (RPF) via clinical manifestations and imaging examinations; 2.Patients complicated with unilateral or bilateral ureteral involvement resulting in hydronephrosis, ureteral obstruction or ureteral stricture; 3.Patients who underwent ureteral stent placement by the Department of Urology (or stent conversion following percutaneous nephrostomy) and were accessible for follow-up observation; 4.Patients with relatively complete medical records, including at least baseline renal function indicators and baseline imaging assessment documentation.

Exclusion criteria

Exclusion criteria: 1.Ureteral obstruction secondary to compression or infiltration of confirmed malignant tumors; 2.Ureteral obstruction predominantly caused by urolithiasis or other definite etiologies unrelated to RPF; 3.Subjects with critical missing data that hinder outcome evaluation (e.g., unavailable follow-up imaging results or renal function records); 4.Subjects judged unsuitable for enrollment at the investigators’ discretion.

Design outcomes

Primary

MeasureTime frame
Successful ureteral stent removal;

Secondary

MeasureTime frame
Anteroposterior diameter of renal pelvis (APD);Estimated glomerular filtration rate (eGFR);

Countries

China

Contacts

Public ContactZhou Liang

West China Hospital of Sichuan University

zhouliang5678@wchscu.cn+86 28 8542 2114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026